Biophytis Sa (BPTS) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access BPTS Annual Income Statement →
By examining income statement figures across successive periods, users can identify shifts in Biophytis Sa's profitability and expense structure.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2023)
Q4 2023
0 0 0 (Dec 31 2021)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing6.15
Research and Development Expense9.91
Other Operating Expense / -Income0.00
Total operating costs including COS16.05
Operating income / -loss-16.05
Net Interest (-)Expense / Income0.00
Other loss / -income3.02
Total costs & expenses19.07
Income & Taxes
Income / -loss before income taxes-19.07
Income after income taxes-19.07
Income / -loss from continuing operations-19.07
Non-controlling interests0.00
Net income / -loss-19.07
Income / -loss to shareholder-19.07
EBIT-19.07
EBITD-19.07
EBITDA-19.07
Earnings Per Share
Basic EPS (excl. extra items)-1.34
Basic Net EPS-1.34
Basic shares outstanding (Mill. of Units)13.58
Diluted Net EPS-1.34
Diluted average shares (Mill. of Units)13.58
4 historic quarters locked

Sign in to unlock the full Biophytis Sa income statement history.

About BPTS Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.